(Q44573110)

4 December 2017

Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients (English)

1 reference

Spontaneous bacterial peritonitis

4 December 2017

1 reference

Grange JD

1

1 reference

4 December 2017

Amiot X

2

1 reference

4 December 2017

Grange V

3

1 reference

4 December 2017

Gutmann L

4

1 reference

4 December 2017

Biour M

5

1 reference

4 December 2017

Bodin F

6

1 reference

4 December 2017

Poupon R

7

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

4 December 2017

1 reference

4 December 2017

11

1 reference

4 December 2017

3

1 reference

4 December 2017

360-364

1 reference

In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin

4 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

Spontaneous bacterial peritonitis in cirrhosis: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Spontaneous Bacterial Peritonitis in Cirrhosis: Endemic or Epidemic?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Naturally-occurring beta-lactamase inhibitors with antibacterial activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Role of anaerobic bacteria in spontaneous peritonitis of cirrhosis: report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent .BETA.-lactamase inhibitor. I. Inhibition of chromosomally and R-factor-mediated .BETA.-lactamases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Amoxicillin-clavulanate potassium-associated cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Nargenicin biosynthesis: late stage oxidations and absolute configuration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110305

7 January 2021

Identifiers

DOI

10.1002/HEP.1840110305

1 reference

4 December 2017

1 reference